Status:
UNKNOWN
PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction
Lead Sponsor:
Tang-Du Hospital
Conditions:
Heroin Addiction
Relapse
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
Heroin addiction is a serious problem and the relapse rate of existing treatment methods is extremely high. Recently, international journals such as Science reported that repetitive transcranial magne...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Heroin-dependent Participants:
- Clinical diagnosis of heroin addiction
- Have been receiving treatment in a methadone maintenance treatment program for no less than 6 months
- have been on a stable dose for at least 1 month before entering the study
- Right-handed
- Inclusion Criteria for Healthy Control Participants:
- Clinical diagnosis of Healthy Control
- Right-handed
- Exclusion Criteria for all Participants:
- Current or past psychiatric illness other than heroin and nicotine dependence
- Neurological signs and/or history of neurological disease
- History of head trauma
- History of cardiovascular or endocrine disease
- Current medical illness or recent medicine use
- Presence of magnetically active objects in the body
- Claustrophobia or any other medical condition that would preclude the participant from lying in the PET/MRI scanner for approximately 40 min.
Exclusion
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04086459
Start Date
June 1 2019
End Date
July 1 2022
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038